“Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management” (2024) International Journal of Pharmaceutical Sciences and Drug Research, 16(5), pp. 777–787. doi:10.25004/IJPSDR.2024.160505.